• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The discriminatory capability of existing scores to predict advanced colorectal neoplasia: a prospective colonoscopy study of 5,899 screening participants.现有评分预测进展期结直肠肿瘤的鉴别能力:一项对5899名筛查参与者的前瞻性结肠镜检查研究
Sci Rep. 2016 Feb 3;6:20080. doi: 10.1038/srep20080.
2
A modified colorectal screening score for prediction of advanced neoplasia: A prospective study of 5744 subjects.改良结直肠筛查评分预测进展性肿瘤:5744 例前瞻性研究。
J Gastroenterol Hepatol. 2018 Jan;33(1):187-194. doi: 10.1111/jgh.13835.
3
Validation of the Asia-Pacific colorectal screening score and its modified versions in predicting colorectal advanced neoplasia in Chinese population.验证亚太结直肠筛查评分及其改良版本在中国人群中预测结直肠高级别瘤变的价值。
BMC Cancer. 2022 Sep 7;22(1):961. doi: 10.1186/s12885-022-10047-y.
4
Prediction of proximal advanced neoplasia: a comparison of four existing sigmoidoscopy-based strategies in a Chinese population.预测近端进展性肿瘤:在中国人群中比较四种基于乙状结肠镜检查的现有策略。
Gut. 2015 May;64(5):776-83. doi: 10.1136/gutjnl-2014-308002. Epub 2014 Sep 1.
5
A validated tool to predict colorectal neoplasia and inform screening choice for asymptomatic subjects.一种经验证的工具,可预测结直肠肿瘤,并为无症状受试者提供筛选选择。
Gut. 2014 Jul;63(7):1130-6. doi: 10.1136/gutjnl-2013-305639. Epub 2013 Sep 17.
6
The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects.亚太结直肠筛查评分:一种经验证的工具,可对无症状亚洲人群结直肠高级别瘤变的风险进行分层。
Gut. 2011 Sep;60(9):1236-41. doi: 10.1136/gut.2010.221168. Epub 2011 Mar 14.
7
Development and validation of a risk stratification-based screening model for predicting colorectal advanced neoplasia in Korea.韩国用于预测结直肠高级别瘤变的基于风险分层的筛查模型的开发与验证
J Clin Gastroenterol. 2015 Jan;49(1):41-9. doi: 10.1097/MCG.0000000000000102.
8
Development and validation of a scoring system to identify individuals at high risk for advanced colorectal neoplasms who should undergo colonoscopy screening.开发并验证一种评分系统,以识别出高危进展性结直肠肿瘤的个体,这些个体应接受结肠镜筛查。
Clin Gastroenterol Hepatol. 2014 Mar;12(3):478-85. doi: 10.1016/j.cgh.2013.08.042. Epub 2013 Sep 8.
9
Capability of four sigmoidoscopy-based screening strategies to predict proximal neoplasia in an asymptomatic Chinese population.四种基于乙状结肠镜检查的筛查策略预测无症状中国人群近端腺瘤的能力。
J Gastroenterol Hepatol. 2019 Apr;34(4):707-712. doi: 10.1111/jgh.14374. Epub 2018 Jul 24.
10
A Risk-Scoring System Combined With a Fecal Immunochemical Test Is Effective in Screening High-Risk Subjects for Early Colonoscopy to Detect Advanced Colorectal Neoplasms.一种结合风险评分系统和粪便免疫化学检测的方法可有效筛查早期结肠镜检查高危人群的进展期结直肠肿瘤。
Gastroenterology. 2016 Mar;150(3):617-625.e3. doi: 10.1053/j.gastro.2015.11.042. Epub 2015 Nov 25.

引用本文的文献

1
Clinical application and effectiveness analysis of modified Asia-Pacific colorectal cancer screening score combined with fecal occult blood test for colorectal cancer screening in asymptomatic population.改良亚太结直肠癌筛查评分联合粪便潜血试验在无症状人群结直肠癌筛查中的临床应用及效果分析
BMC Gastroenterol. 2025 Mar 31;25(1):212. doi: 10.1186/s12876-025-03779-1.
2
Risk prediction of advanced colorectal neoplasia varies by race and neighbourhood socioeconomic status.结直肠高级别瘤变的风险预测因种族和社区社会经济地位而异。
Fam Med Community Health. 2024 May 30;12(Suppl 2):e002892. doi: 10.1136/fmch-2024-002892.
3
Risk prediction of advanced colorectal neoplasia among diabetic patients: A derivation and validation study.糖尿病患者晚期结直肠肿瘤的风险预测:一项推导与验证研究。
JGH Open. 2024 May 13;8(5):e13062. doi: 10.1002/jgh3.13062. eCollection 2024 May.
4
An adjusted Asia-Pacific colorectal screening score system to predict advanced colorectal neoplasia in asymptomatic Chinese patients.亚太结直肠筛查评分系统调整版预测无症状中国人群中结直肠进展期腺瘤的价值。
BMC Gastroenterol. 2023 Jun 29;23(1):223. doi: 10.1186/s12876-023-02860-x.
5
Application of the postnatal urinary tract dilation classification system to predict the need for surgical intervention among neonates and young infants.产后泌尿道扩张分类系统在预测新生儿和婴幼儿手术干预需求中的应用。
Ultrasonography. 2023 Jan;42(1):136-146. doi: 10.14366/usg.22035. Epub 2022 Jul 23.
6
A scoping review of risk-stratified bowel screening: current evidence, future directions.风险分层肠道筛查的范围综述:当前证据,未来方向。
Cancer Causes Control. 2022 May;33(5):653-685. doi: 10.1007/s10552-022-01568-9. Epub 2022 Mar 20.
7
The classification capability of the Asia Pacific Colorectal Screening score in Korea: an analysis of the Cancer Screenee Cohort.亚太结直肠癌筛查评分在韩国的分类能力:癌症筛查队列分析。
Epidemiol Health. 2021;43:e2021069. doi: 10.4178/epih.e2021069. Epub 2021 Sep 16.
8
Children's Hepatic Tumors International Collaboration-Hepatoblastoma Stratification (CHIC-HS) System for Pediatric Patients with Hepatoblastoma: A Retrospective, Hospital-Based Cohort Study in South Korea.儿童肝脏肿瘤国际协作组织-肝母细胞瘤分层(CHIC-HS)系统在韩国:一项回顾性、基于医院的肝母细胞瘤患儿队列研究。
Cancer Res Treat. 2022 Jan;54(1):253-258. doi: 10.4143/crt.2021.265. Epub 2021 Mar 24.
9
Prognostic Factors for Event-Free Survival in Pediatric Patients with Hepatoblastoma Based on the 2017 PRETEXT and CHIC-HS Systems.基于2017年PRETEXT和CHIC-HS系统的儿童肝母细胞瘤无事件生存的预后因素
Cancers (Basel). 2019 Sep 18;11(9):1387. doi: 10.3390/cancers11091387.
10
Head-to-Head Comparison of the Performance of 17 Risk Models for Predicting Presence of Advanced Neoplasms in Colorectal Cancer Screening.头对头比较 17 种风险模型在预测结直肠癌筛查中晚期肿瘤存在的性能。
Am J Gastroenterol. 2019 Sep;114(9):1520-1530. doi: 10.14309/ajg.0000000000000370.

本文引用的文献

1
Prediction of proximal advanced neoplasia: a comparison of four existing sigmoidoscopy-based strategies in a Chinese population.预测近端进展性肿瘤:在中国人群中比较四种基于乙状结肠镜检查的现有策略。
Gut. 2015 May;64(5):776-83. doi: 10.1136/gutjnl-2014-308002. Epub 2014 Sep 1.
2
Development of a risk score to stratify symptomatic adults referred for colonoscopy.用于对接受结肠镜检查的有症状成年人进行风险分层的风险评分的开发。
J Gastroenterol Hepatol. 2014 Nov;29(11):1890-6. doi: 10.1111/jgh.12638.
3
An updated Asia Pacific Consensus Recommendations on colorectal cancer screening.亚太结直肠癌筛查共识推荐意见更新版。
Gut. 2015 Jan;64(1):121-32. doi: 10.1136/gutjnl-2013-306503. Epub 2014 Mar 19.
4
Development and validation of a risk stratification-based screening model for predicting colorectal advanced neoplasia in Korea.韩国用于预测结直肠高级别瘤变的基于风险分层的筛查模型的开发与验证
J Clin Gastroenterol. 2015 Jan;49(1):41-9. doi: 10.1097/MCG.0000000000000102.
5
A score to estimate the likelihood of detecting advanced colorectal neoplasia at colonoscopy.一种用于评估结肠镜检查中发现晚期结直肠肿瘤可能性的评分。
Gut. 2014 Jul;63(7):1112-9. doi: 10.1136/gutjnl-2013-304965. Epub 2014 Jan 2.
6
Long-term colorectal-cancer incidence and mortality after lower endoscopy.结肠镜检查后的结直肠癌长期发病率和死亡率。
N Engl J Med. 2013 Sep 19;369(12):1095-105. doi: 10.1056/NEJMoa1301969.
7
A validated tool to predict colorectal neoplasia and inform screening choice for asymptomatic subjects.一种经验证的工具,可预测结直肠肿瘤,并为无症状受试者提供筛选选择。
Gut. 2014 Jul;63(7):1130-6. doi: 10.1136/gutjnl-2013-305639. Epub 2013 Sep 17.
8
Development and validation of a scoring system to identify individuals at high risk for advanced colorectal neoplasms who should undergo colonoscopy screening.开发并验证一种评分系统,以识别出高危进展性结直肠肿瘤的个体,这些个体应接受结肠镜筛查。
Clin Gastroenterol Hepatol. 2014 Mar;12(3):478-85. doi: 10.1016/j.cgh.2013.08.042. Epub 2013 Sep 8.
9
Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths.结肠镜息肉切除术与结直肠癌死亡的长期预防。
N Engl J Med. 2012 Feb 23;366(8):687-96. doi: 10.1056/NEJMoa1100370.
10
Derivation and validation of a prediction rule for estimating advanced colorectal neoplasm risk in average-risk Chinese.基于中国一般风险人群的预测规则的推导和验证,用于评估结直肠高级别瘤变风险。
Am J Epidemiol. 2012 Mar 15;175(6):584-93. doi: 10.1093/aje/kwr337. Epub 2012 Feb 10.

现有评分预测进展期结直肠肿瘤的鉴别能力:一项对5899名筛查参与者的前瞻性结肠镜检查研究

The discriminatory capability of existing scores to predict advanced colorectal neoplasia: a prospective colonoscopy study of 5,899 screening participants.

作者信息

Wong Martin C S, Ching Jessica Y L, Ng Simpson, Lam Thomas Y T, Luk Arthur K C, Wong Sunny H, Ng Siew C, Ng Simon S M, Wu Justin C Y, Chan Francis K L, Sung Joseph J Y

机构信息

Institute of Digestive Disease, Chinese University of Hong Kong, 7/F, Lui Che Woo Clinical Science Building, Prince of Wales Hospital, Shatin, NT, HKSAR.

School of Public Health and Primary Care, Chinese University of Hong Kong, Shatin, 4/F, School of Public Health Building, Prince of Wales Hospital, Shatin, NT, Hong Kong, HKSAR, China.

出版信息

Sci Rep. 2016 Feb 3;6:20080. doi: 10.1038/srep20080.

DOI:10.1038/srep20080
PMID:26838178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4738273/
Abstract

We evaluated the performance of seven existing risk scoring systems in predicting advanced colorectal neoplasia in an asymptomatic Chinese cohort. We prospectively recruited 5,899 Chinese subjects aged 50-70 years in a colonoscopy screening programme(2008-2014). Scoring systems under evaluation included two scoring tools from the US; one each from Spain, Germany, and Poland; the Korean Colorectal Screening(KCS) scores; and the modified Asia Pacific Colorectal Screening(APCS) scores. The c-statistics, sensitivity, specificity, positive predictive values(PPVs), and negative predictive values(NPVs) of these systems were evaluated. The resources required were estimated based on the Number Needed to Screen(NNS) and the Number Needed to Refer for colonoscopy(NNR). Advanced neoplasia was detected in 364 (6.2%) subjects. The German system referred the least proportion of subjects (11.2%) for colonoscopy, whilst the KCS scoring system referred the highest (27.4%). The c-statistics of all systems ranged from 0.56-0.65, with sensitivities ranging from 0.04-0.44 and specificities from 0.74-0.99. The modified APCS scoring system had the highest c-statistics (0.65, 95% C.I. 0.58-0.72). The NNS (12-19) and NNR (5-10) were similar among the scoring systems. The existing scoring systems have variable capability to predict advanced neoplasia among asymptomatic Chinese subjects, and further external validation should be performed.

摘要

我们评估了七种现有风险评分系统在预测无症状中国队列中晚期结直肠肿瘤方面的性能。我们在一项结肠镜筛查项目(2008 - 2014年)中前瞻性招募了5899名年龄在50 - 70岁的中国受试者。评估的评分系统包括来自美国的两种评分工具;分别来自西班牙、德国和波兰的各一种;韩国结直肠癌筛查(KCS)评分;以及改良的亚太结直肠癌筛查(APCS)评分。对这些系统的c统计量、敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)进行了评估。根据筛查所需人数(NNS)和结肠镜检查转诊所需人数(NNR)估算了所需资源。在364名(6.2%)受试者中检测到晚期肿瘤。德国系统转诊进行结肠镜检查的受试者比例最低(11.2%),而KCS评分系统转诊比例最高(27.4%)。所有系统的c统计量范围为0.56 - 0.65,敏感性范围为0.04 - 0.44,特异性范围为0.74 - 0.99。改良的APCS评分系统具有最高的c统计量(0.65,95%置信区间0.58 - 0.72)。各评分系统之间的NNS(12 - 19)和NNR(5 - 10)相似。现有评分系统在预测无症状中国受试者晚期肿瘤方面的能力各不相同,应进行进一步的外部验证。